Search Cidpusa web
A Laboratory-Made Disease Agent Return to part -1
VII - TESTING FOR MYCOPLASMA IN YOUR BODY
Blood Volume Test
You can also ask your doctor for a blood volume test. Every human being requires a certain amount of blood per pound of body weight, and it has been observed that people with fibromyalgia, chronic fatigue syndrome, multiple sclerosis and other illnesses do not have the normal blood volume their body needs to function properly. Doctors aren't normally aware of this.
This test measures the amount of blood in the human body by taking out 5 cc, putting a tracer in it and then putting it back into the body. One hour later, take out 5 cc again and look for the tracer. The thicker the blood and the lower the blood volume, the more tracer you will find.
The analysis of one of my clients stated: "This patient was referred for red cell mass study. The red cell volume is 16.9 ml per kg of body weight. The normal range is 25 to 35 ml per kg. This guy has 36% less blood in his body than the body needs to function." And the doctor hadn't even known the test existed.
If you lost 36% of your blood in an accident, do you think your doctor would tell you that you are alright and should just take up line dancing and get over it? They would rush you to the nearest hospital and start transfusing you with blood. These tragic people with these awful diseases are functioning with anywhere from 7% to 50% less blood than their body needs to function.
VII – UNDOING THE DAMAGE
The body undoes the damage itself. The scarring in the brain of people with chronic fatigue and fibromyalgia will be repaired. There is cellular repair going on all the time. But the mycoplasmahas moved on to the next cell.
In the early stages of a disease, doxycycline may reverse that disease process. It is one of the tetracycline antibiotics, but it is not bactericidal; it is bacteriostatic--it stops the growth of the mycoplasma. And if the mycoplasma growth can be stopped for long enough, then the immune system takes over.
Doxycycline treatment is discussed in a paper by mycoplasma expert Professor Garth Nicholson, PhD, of the Institute for Molecular Medicine.15 Dr Nicholson is involved in a US$8-million mycoplasma research program funded by the US military and headed by Dr Charles Engel of the NIH. The program is studying Gulf War veterans, 450 of them, because there is evidence to suggest that Gulf War syndrome is another illness (or set of illnesses) caused by mycoplasma.
1. "Pathogenic Mycoplasma", US Patent No. 5,242,820, issued September 7, 1993. Dr Lo is listed as the "Inventor" and the American Registry of Pathology, Washington, DC, is listed as the "Assignee".
2. "Special Virus Cancer Program: Progress Report No. 8", prepared by the National Cancer Institute, Viral Oncology, Etiology Area, July 1971, submitted to NIH Annual Report in May 1971 and updated July 1971.
3. US Senate, Ninety-fifth Congress, Hearings before the Subcommittee on Health and Scientific Research of the Committee on Human Resources, Biological Testing Involving Human Subjects by the Department of Defense, 1977; released as US Army Activities in the US Biological Warfare Programs, Volumes One and Two, 24 February 1977.
4. Dr Donald MacArthur, Pentagon, Department of Defense Appropriations for 1970, Hearings before Subcommittee of the Committee on Appropriations, House of Representatives, Ninety-First Congress, First Session, Monday June 9, 1969, pp 105&endash;144, esp. pp. 114, 129.
5. Kyger, E. R. and Russell L. Haden, "Brucellosis and Multiple Sclerosis", The American Journal of Medical Sciences 1949:689-693.
6. Colmonero et al., "Complications Associated with Brucella melitensis Infection: A Study of 530 Cases", Medicine 1996;75(4).
7. Howell, Miller, Kelly and Bookman, "Acute Brucellosis Among Laboratory Workers", New England Journal of Medicine 1948;236:741.
8. "Special Virus Cancer Program: Progress Report No. 8", ibid., table 4, p. 135.
9. US Senate, Hearings before the Subcommittee on Health and Scientific Research of the Committee on Human Resources, March 8 and May 23, 1977, ibid.
10. New England Journal of Medicine, August 22, 1957, p. 362.
11. Toronto Star, May 15, 1997.
12. Dr Donald MacArthur, Pentagon, Department of Defense Appropriations for 1970, Hearings, Monday June 9, 1969, ibid., p. 129.
13. Henderson, Donald A., "Smallpox: Epitaph for a Killer", National Geographic, December 1978, p. 804.
14. Blum, Deborah, The Monkey Wars, Oxford University Press, New York, 1994.
15. Nicholson, G. L., "Doxycycline treatment and Desert Storm", JAMA 1995;273:618-619.
About the Author:
Donald Scott, MA, MSc, is a retired high school teacher and university professor. He is also a veteran of WWII and was awarded the North Atlantic Star, the Burma Star with Clasp, the 1939 - 1945
Volunteer Service Medal and the Victory Medal. He is currently President of The Common Cause Medical Research Foundation, a not-for-profit organization devoted to research into neurosystemic degenerative diseases. He is also Adjunct Professor with the Institute for Molecular Medicine and he produces and edits the Journal of Degenerative Diseases. He has extensively researched neurosystemic degenerative diseases over the past five years and has authored many documents on the relationship between degenerative diseases and a pathogenic mycoplasma called Mycoplasma fermentans. His research is based upon solid government evidence.